vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and TEJON RANCH CO (TRC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $21.1M, roughly 1.9× TEJON RANCH CO). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 7.5%, a 28.4% gap on every dollar of revenue. On growth, TEJON RANCH CO posted the faster year-over-year revenue change (17.7% vs -10.9%). Over the past eight quarters, TEJON RANCH CO's revenue compounded faster (68.8% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
Tejon Ranch Company, based in Lebec, California, is one of the largest private landowners in California. The company was incorporated in 1936 to organize the ownership of a large tract of land that was consolidated from four Mexican land grants acquired in the 1850s and 1860s by ranch founder Edward Fitzgerald Beale.
SBC vs TRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $21.1M |
| Net Profit | $14.2M | $1.6M |
| Gross Margin | 73.1% | 30.6% |
| Operating Margin | 32.5% | 10.9% |
| Net Margin | 35.9% | 7.5% |
| Revenue YoY | -10.9% | 17.7% |
| Net Profit YoY | 117.2% | -64.7% |
| EPS (diluted) | $0.15 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $21.1M | ||
| Q3 25 | $43.4M | $12.0M | ||
| Q2 25 | $43.4M | $8.3M | ||
| Q1 25 | $47.3M | $8.2M | ||
| Q4 24 | $44.4M | $17.9M | ||
| Q3 24 | $53.1M | $10.9M | ||
| Q2 24 | $53.1M | $5.7M | ||
| Q1 24 | $54.8M | $7.4M |
| Q4 25 | $14.2M | $1.6M | ||
| Q3 25 | $12.8M | $1.7M | ||
| Q2 25 | $2.5M | $-1.7M | ||
| Q1 25 | $21.5M | $-1.5M | ||
| Q4 24 | $6.5M | $4.5M | ||
| Q3 24 | $2.8M | $-1.8M | ||
| Q2 24 | $18.5M | $957.0K | ||
| Q1 24 | $18.8M | $-914.0K |
| Q4 25 | 73.1% | 30.6% | ||
| Q3 25 | 70.6% | 28.4% | ||
| Q2 25 | 69.2% | 40.9% | ||
| Q1 25 | 79.7% | 15.0% | ||
| Q4 24 | 76.3% | 42.9% | ||
| Q3 24 | 81.5% | 22.9% | ||
| Q2 24 | 74.2% | 45.3% | ||
| Q1 24 | 72.1% | 0.3% |
| Q4 25 | 32.5% | 10.9% | ||
| Q3 25 | 36.6% | -16.9% | ||
| Q2 25 | 33.6% | -48.8% | ||
| Q1 25 | 51.1% | -50.7% | ||
| Q4 24 | 10.6% | 11.9% | ||
| Q3 24 | 26.1% | -34.9% | ||
| Q2 24 | 51.4% | -62.4% | ||
| Q1 24 | 44.6% | -53.8% |
| Q4 25 | 35.9% | 7.5% | ||
| Q3 25 | 29.6% | 14.0% | ||
| Q2 25 | 5.7% | -20.6% | ||
| Q1 25 | 45.4% | -17.8% | ||
| Q4 24 | 14.7% | 25.0% | ||
| Q3 24 | 5.3% | -16.9% | ||
| Q2 24 | 34.8% | 16.8% | ||
| Q1 24 | 34.2% | -12.3% |
| Q4 25 | $0.15 | $0.05 | ||
| Q3 25 | $0.12 | $0.06 | ||
| Q2 25 | $0.02 | $-0.06 | ||
| Q1 25 | $0.21 | $-0.05 | ||
| Q4 24 | $0.05 | $0.16 | ||
| Q3 24 | $0.03 | $-0.07 | ||
| Q2 24 | $0.20 | $0.04 | ||
| Q1 24 | $0.20 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $9.5M |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $475.2M |
| Total Assets | $380.4M | $630.5M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | $9.5M | ||
| Q3 25 | $127.4M | $3.6M | ||
| Q2 25 | $152.7M | $2.5M | ||
| Q1 25 | $132.1M | $12.3M | ||
| Q4 24 | $125.0M | $39.3M | ||
| Q3 24 | $137.4M | $27.4M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $35.6M |
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $823.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $475.2M | ||
| Q3 25 | $248.0M | $473.2M | ||
| Q2 25 | $244.6M | $471.5M | ||
| Q1 25 | $226.4M | $472.5M | ||
| Q4 24 | $195.1M | $473.6M | ||
| Q3 24 | $205.0M | $468.3M | ||
| Q2 24 | $8.8M | $469.2M | ||
| Q1 24 | $9.0M | $467.4M |
| Q4 25 | $380.4M | $630.5M | ||
| Q3 25 | $321.4M | $629.6M | ||
| Q2 25 | $315.3M | $618.5M | ||
| Q1 25 | $284.6M | $614.6M | ||
| Q4 24 | $266.1M | $608.0M | ||
| Q3 24 | $296.5M | $598.0M | ||
| Q2 24 | $19.5M | $590.8M | ||
| Q1 24 | $19.8M | $581.6M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $6.1M |
| Free Cash FlowOCF − Capex | $51.2M | — |
| FCF MarginFCF / Revenue | 129.3% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 3.66× | 3.88× |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $6.1M | ||
| Q3 25 | $-20.9M | $-2.4M | ||
| Q2 25 | $-8.3M | $-381.0K | ||
| Q1 25 | $1.9M | $-1.3M | ||
| Q4 24 | $-7.3M | $14.3M | ||
| Q3 24 | $5.0M | $2.1M | ||
| Q2 24 | $19.2M | $-1.8M | ||
| Q1 24 | $3.7M | $777.0K |
| Q4 25 | $51.2M | — | ||
| Q3 25 | $-20.9M | $-14.6M | ||
| Q2 25 | $-8.6M | $-20.0M | ||
| Q1 25 | $1.7M | $-18.9M | ||
| Q4 24 | $-7.9M | $-42.9M | ||
| Q3 24 | $4.6M | $-16.8M | ||
| Q2 24 | $18.3M | $-15.8M | ||
| Q1 24 | $3.0M | $-7.3M |
| Q4 25 | 129.3% | — | ||
| Q3 25 | -48.3% | -122.2% | ||
| Q2 25 | -19.9% | -240.6% | ||
| Q1 25 | 3.5% | -230.1% | ||
| Q4 24 | -17.8% | -239.3% | ||
| Q3 24 | 8.7% | -155.2% | ||
| Q2 24 | 34.5% | -277.2% | ||
| Q1 24 | 5.4% | -99.0% |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 0.1% | 102.3% | ||
| Q2 25 | 0.7% | 236.0% | ||
| Q1 25 | 0.5% | 213.7% | ||
| Q4 24 | 1.3% | 319.1% | ||
| Q3 24 | 0.8% | 174.3% | ||
| Q2 24 | 1.6% | 245.5% | ||
| Q1 24 | 1.3% | 109.5% |
| Q4 25 | 3.66× | 3.88× | ||
| Q3 25 | -1.63× | -1.43× | ||
| Q2 25 | -3.39× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | -1.12× | 3.19× | ||
| Q3 24 | 1.77× | — | ||
| Q2 24 | 1.04× | -1.88× | ||
| Q1 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
TRC
Segment breakdown not available.
